Retrospective study on the cutaneous head and neck melanoma in Dorset (UK)

British Journal of Oral and Maxillofacial Surgery

Volumn 49, Issue 5, 2011, Pages 359-363

  Komisarovas, Larissa ^a   Jayasinghe, Chandima ^a   Seah, Tian Ee ^b   Ilankovan, Velupillai ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b National Dental Centre of Singapore   (Singapore)

Author keywords

Dorset; Head and neck; Malignant melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; METASTASIS; PRIMARY TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ULCER; UNITED KINGDOM;

AGE FACTORS; AGED; ENGLAND; FACIAL NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 79959292414     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2010.06.016     Document Type: Article

References (24)

1. Daryanani D, Plukker JT, de Jong MA, Haaxma-Reiche H, Nap R, Kuiper H, et al. Increased incidence of brain metastases in cutaneous head and neck melanoma. Melanoma Research 2005;15(2):119-24. (Pubitemid 40637990)
2. MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. The Lancet 2002;360:587-91. (Pubitemid 35232190)
3. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. Journal of the National Cancer Institute 2001;93:678-83. (Pubitemid 32492808)
4. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New SouthWales, 1983-1996. International Journal of Cancer 2001;92:457-62.
5. Cancer Research UK. UK cancer incidence statistics for common cancers; 2006. http://info.cancerresearchuk.org. Accessed September 7th, 2009.
6. Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. International Journal of Cancer 1993;53:585-90. (Pubitemid 23069268)
7. Levi F, Franceschi S, Te V-C, Randimbison L, La Vecchia C. Trends of skin cancer in the Canton of Vaud, 1976-92. British Journal of Cancer 1995;72:1047-53.
8. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase of incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. International Journal of Cancer 1999;81:555-9. (Pubitemid 29203052)
9. Omari AK, Khammash MR, Matalka I. Skin cancer trends in Northern Jordan. International Journal of Dermatology 2006;45:384-8.
10. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the surveillance, epidemiology, and end results (SEER) program. Archives of Dermatology 2008;144(4):515-21. (Pubitemid 351581109)
11. Kienstra MA, Padhya TA. Head and neck melanoma. Cancer Control 2005;12(4):242-7. (Pubitemid 41552316)
12. Ringborg U, Afzelius LE, Lagerlöf B, Adami HO, Augustsson I, Blomqvist E, et al. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report for the Swedish melanoma study group. Cancer 1993;71(3):751-8. (Pubitemid 23051378)
13. Gillgren P, Månsson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U. A prospective population-based study of cutaneous malignant melanoma of the head and neck. The Laryngoscope 2000;110:1498-504.
14. Dorset County Council. Statistics and census information: key facts on population; 2007. http://www.dorsetforyou.com/index.jsp?articleid=344105. Accessed January 4th, 2010.
15. Clark Jr WH, From L, Bernadino EA, Mihm MC. The histogenesis and biologic behaviour of primary human malignant melanoma of the skin. Cancer Research 1969;29:705-26.
16. Breslow A. Thickness, cross-sectional areas and depth of invasion in prognosis of cutaneous melanoma. Annals of Surgery 1970;172:902-6.
17. Golger A, Young DS, Ghazarian D, Neligan PC. Epidemiological features and prognostic factors of cutaneous head and neck melanoma. Archives of Otolaryngology-Head & Neck Surgery 2007;133:442-7. (Pubitemid 46799779)
18. Cox NH, Aitchison TC, Sirel JM, MacKie RM. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. British Journal of Cancer 1996;73:940-4. (Pubitemid 26110168)
19. Fisher SR. Cutaneous malignant melanoma of head and neck. The Laryngoscope 1989;99:822-36. (Pubitemid 19199965)
20. O'Brien CJ, Coates AS, Petersen-Schaefer K, Shannon K, Thompson JF, Milton GW, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. The American Journal of Surgery 1991;162:310-4.
21. Thörn M, Adami HO, Ringborg U, Bergströms R, Krusemo U. The association between anatomic site and survival in malignant melanoma. An analysis of 12353 cases from the Swedish cancer registry. European Journal of Cancer & Clinical Oncology 1989;25:483-91. (Pubitemid 19061769)
22. Pathak I, O'Brien CJ, Petersen-Schaeffer K, McNeil EB, McMahon J, Quinn MJ, et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head and Neck 2001;23(9):785-90. (Pubitemid 32751496)
23. Matin RN, Mesher D, Proby CM, McGregor JM, Bouwes Bavinck JN, del Marmol V, et al. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. American Journal of Transplantation 2008;8:1891-900.
24. Vajdic CM, van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, Chapman JR, et al. Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiology, Biomarkers & Prevention 2009;18(8):2297-303.